Clinical Development Lifecycle
Lifecycle Support Beyond Registration
Clinical development does not end at registration. Phase IV and post-marketing research generates the real-world evidence, long-term safety data and effectiveness information that regulators, physicians and patients increasingly expect.
Evestia Clinical supports sponsors through the full scope of post-approval development, from Phase III registration through Phase IV studies, observational research, post-authorization safety studies (PASS) and ongoing lifecycle management.
Post-Approval and Post-Marketing Research
Phase IV Studies
Post-approval studies evaluating safety, effectiveness and long-term outcomes in broader patient populations.
Observational Studies
Real-world observational research including retrospective and prospective cohort studies.
PASS Studies
Post-authorization safety studies meeting regulatory commitments and risk management plan obligations.
Post-Authorization Commitments
Supporting sponsors in fulfilling post-authorization commitments and special obligations.
Regulatory Obligations and Lifecycle Commitments
Post-approval development involves ongoing regulatory obligations, including post-authorization commitments, special obligations and risk management plan requirements. Evestia Clinical helps sponsors manage these commitments through coordinated Regulatory Affairs and safety expertise.
Our integrated teams ensure that post-marketing safety data, regulatory reporting and lifecycle documentation are managed consistently from registration through the full commercial lifecycle.
Post-authorization commitment management
Risk management plan maintenance
Regulatory lifecycle reporting
Variation and renewal support
Post-marketing safety reporting
Benefit-risk evaluation updates
Capabilities Supporting Post-Marketing Programs
Phase IV and post-marketing programs draw on the same integrated medical, scientific and operational expertise that supports earlier development phases.
Post-Marketing Safety
Post-marketing safety surveillance, adverse event collection and signal management integrated with Pharmacovigilance.
Learn moreSafety Writing
Aggregate safety reports, risk management plans and post-marketing safety documentation.
Learn moreMedical Affairs
Physician-led medical oversight and benefit-risk assessment throughout the post-marketing period.
Learn moreData Management & Biostatistics
Post-marketing data collection, analysis and statistical reporting for regulatory submissions.
Learn moreExplore Related Services